In November 2021, we reviewed the evidence on SGLT2 inhibitors for adults with type 2 diabetes and chronic kidney disease, and made new recommendations (NICE)
Diabetes News
Category: Guidance
Type 2 diabetes in adults: management – glucose monitoring
Consultation documents (NICE)
Type 1 diabetes in adults: diagnosis and management – glucose monitoring and diagnosis
Consultation documents (NICE)
Diabetes (type 1 and type 2) in children and young people: diagnosis and management – glucose monitoring
Consultation documents (NICE)
Chronic kidney disease: assessment and management
This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with CKD (NICE)
Type 2 diabetes in adults
Type 2 diabetes in adults – everything NICE says in an interactive flowchart (NICE)
Type 1 diabetes in adults
Type 1 diabetes in adults – everything NICE says in an interactive flowchart (NICE)
FDA Proposes Broad Approach for Conducting Safety Trials for Type 2 Diabetes Medications
New Draft Guidance Considers Broader Evaluations Beyond Cardiovascular Outcomes Trials
The Physical Activity Guidelines for Americans
The Physical Activity Guidelines for Americans, 2nd edition, provides information and guidance on the types and amounts of physical activity that provide substantial health benefits (JAMA)
Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
Our data suggested that older male patients with newly diagnosed T2D may have lower nocturnal glucose concentrations. This may potentially increase the risk of nocturnal hypoglycemia during CSII therapy (Journal of Diabetes Research)
Diabetes Technology – Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults
An Endocrine Society Clinical Practice Guideline (Journal of Clinical Endocrinology & Metabolism)
Type 1 diabetes in adults: diagnosis and management
This guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes (NICE)
Type 2 diabetes in adults: management
This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)
Kindness Matters: A Randomized Controlled Trial of a Mindful Self-Compassion Intervention Improves Depression, Distress, and HbA1c Among Patients With Diabetes
This initial report suggests that learning to be kinder to oneself (rather than being harshly self-critical) may have both emotional and metabolic benefits among patients with diabetes (Diabetes Care)
Starting injectable treatment in adults with Type 2 diabetes: RCN guidance
This new edition provides information relating to GLP 1 therapy action, including the implications for use and the aspects of education that need to be addressed with users. This guidance is intended for nurses new to insulin therapy, and includes an overview of the underlying principles for starting insulin along with practical tips on education, adjustment of doses, and dealing with difficult situations (RCN)
Glycosmedia is also available as an App: